Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
COVIDMENT [www.covidment.is] is a NordForsk-funded research collaboration across six nations, with the overarching aim to significantly advance current knowledge on mental morbidity trajectories associated with the coronavirus disease 2019 (COVID-19) in the general population and in specific risk groups. From March 2020 through August 2021, 392 817 individuals have been recruited to the seven COVIDMENT cohorts: the Danish Blood Donor Study (N = 71 562), the Estonian Biobank COVID-19 and Mental Health Data Collection cohorts (N = 13 329 and N = 86 116, respectively), the Icelandic COVID-19 National Resilience Cohort (N = 22 849), the Norwegian BRY.DEG2020 (N = 19 343), the Norwegian Mother, Father and Child Cohort Study (N = 132 486), the Scottish Generation Scotland/CovidLife (N = 18 518) and the Swedish Omtanke2020 (N = 28 614). Semi-harmonized questionnaire data have been collected across all COVIDMENT cohorts with longitudinal data available, e.g. through linkage to the national registers. The average age of participants ranged from 31.8 to 58.5 years across cohorts. The prevalence of depressive symptoms above cut-off point varied considerably across cohorts (4.2–20.8%). The prevalence of depressive symptoms was highest at COVID-19 incidence of 30 cases per week per 100 000 persons, i.e. 14.3% [95% confidence interval (CI): 9.4–21.8%], which was 61.0% (95% CI: 34.0–94.1%) higher than the prevalence at COVID-19 incidence of 0 cases per week per 100 000 persons (P = 1.1 x 10 ^(−6)). We welcome proposals for collaboration; please visit our website [www.covidment.is] for further information. With more than 218 million cases and 4.5 million deaths worldwide (Worldometers, 31 August 2021), the COVID-19 pandemic has had an unprecedented influence on the global economy and population health. As a potent global disaster, it is likely to significantly affect the incidence of adverse mental health symptoms and psychiatric disorders, particularly in vulnerable and highly affected populations. The World Health Organization and leading scientific journals have alerted concerning the potential adverse mental health impact of COVID-19 and emphasized the need for multinational research in this area,1,2 which additionally provides new insights into disease mechanisms.2 Although a substantial number of studies on the mental health effects of COVID-19 has been published, the existing literature is largely limited by relatively small studies of convenience samples without pre-pandemic data, longitudinal data or cross-national comparisons.3,4 Some,5,6 but not all7,8 studies have reported evidence for a negative impact on mental health in the general adult population, including a rise in prevalence of symptoms of anxiety9 and depression10,11 during the COVID-19 pandemic. Previous history of psychiatric problems,12 higher age13 and female sex14 have been suggested as risk factors for mental health problems during the COVID-19 pandemic, although the weight of these factors is bound to vary over time and geographical areas and largely depends on the severity of outbreaks. Furthermore, COVID-19-mandated restrictions, such as quarantine measures, complete or partial lockdown and isolation, have been associated with deterioration in mental health15–17 and so has dissatisfaction with governmental pandemic mitigations.18 The severity of the pandemic and mitigating strategies has varied considerably across countries. For example, as of 31 August 2021, the cumulative number of deaths due to COVID-19 stands at 1940 per one million inhabitants in the UK, 1440 in Sweden, 973 in Estonia, 444 in Denmark, 149 in Norway and 96 in Iceland (Worldometers, 2021). The variation in national pandemic response efforts and actual disease burden have implications for the proportion of citizens with first-hand exposure to COVID-19. Furthermore, mitigation responses may also affect health behaviours, social interactions, sense of security and trust in authorities, with potential downstream impact on population mental health. A key objective of the COVIDMENT initiative is to investigate whether differences in disease burden and mitigating responses to COVID-19 across countries (displayed in Figure 1) impact on psychiatric symptoms and disorders. Daily COVID-19 cases per 100 000 persons, changes in social gathering restrictions (green means looser restrictions and red means stricter, according to Oxford COVID-19 Government Response Tracker) and timeline of waves (W) of data collections in each cohort Daily COVID-19 cases per 100 000 persons, changes in social gathering restrictions (green means looser restrictions and red means stricter, according to Oxford COVID-19 Government Response Tracker) and timeline of waves (W) of data collections in each cohort Due to the relatively narrow time window since the start of the pandemic, the long-term mental health consequences in exposed populations during the COVID-19 pandemic (i.e. patients, loved ones and front-li
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
Holmes, E. A., O'Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., Ballard, C., Christensen, H., Cohen Silver, R., Everall, I., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30168-1 · Cited by 5,715 · cited 1×
“of COVID-19 and emphasized the need for multinational research in this area,(1,2) which additionally provides new insights into disease mechanisms.(2) Although a substantial number of studies on the mental health effects of COVID-19 has been published, the existing literature is largely limited by relatively small stu…”
A Short Scale for Measuring Loneliness in Large Surveys: Results From Two Population-Based Studies
Hughes, M. E., Waite, L. J., Hawkley, L. C., & Cacioppo, J. T. (2004) · Research on Aging · doi:10.1177/0164027504268574 · Cited by 4,781
COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
Vindegaard, N., & Benros, M. E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.048 · Cited by 3,221 · cited 1×
“Although a substantial number of studies on the mental health effects of COVID-19 has been published, the existing literature is largely limited by relatively small studies of convenience samples without pre-pandemic data, longitudinal data or cross-national comparisons.(3,4) Some,(5,6) but not all(7,8) studies have r…”
BackgroundDevelopment of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032
Pierce, M., Hope, H., Ford, T., Hatch, S., Hotopf, M., John, A., Kontopantelis, E., Webb, R., Wessely, S., McManus, S., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30308-4 · Cited by 2,621
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407 · cited 1×
“Although a substantial number of studies on the mental health effects of COVID-19 has been published, the existing literature is largely limited by relatively small studies of convenience samples without pre-pandemic data, longitudinal data or cross-national comparisons.(3,4) Some,(5,6) but not all(7,8) studies have r…”
Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic
Ettman, C. K., Abdalla, S. M., Cohen, G. H., Sampson, L., Vivier, P. M., & Galea, S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19686 · Cited by 2,138
Metadata
- Authors
- Unnarsdóttir, A. B., Lovik, A., Fawns-Ritchie, C., Ask, H., Kõiv, K., Hagen, K., Didriksen, M., Christoffersen, L. A. N., Garðarsson, A. B., McIntosh, A., Kähler, A. K., Campbell, A., Hauksdóttir, A., Erikstrup, C., Mikkelsen, D. H., Altschul, D., Thordardottir, E. B., Frans, E. M., Kvale, G., Tómasson, G., Kariis, H. M., Jónsdóttir, H. L., Rúnarsdóttir, H., Magnúsdóttir, I., Eid, J., Jakobsdóttir, J., Nielsen, K. R., Kaspersen, K. A., Milani, L., Trogstad, L.-I. S., Yi, L., Bruun, M. T., Sullivan, P. F., Magnus, P. M., Shen, Q., Nesvåg, R., Brandlistuen, R. E., Mägi, R., Ostrowski, S. R., Løkhammer, S., Solem, S., Reichborn-Kjennerud, T., Hansen, T. F., Werge, T., Aspelund, T., Porteous, D. J., Fang, F., Lehto, K., Andreassen, O. A., Pedersen, O. B. V., Hellard, S. L., & Valdimarsdóttir, U. A.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-20
- Volume
- 51
- Issue
- 3
- Pages
- e108-e122
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W4205784448
- Cited by
- 159
- References
- 20
- FWCI
- 24.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. https://app.cochat.ai/papers/10.1093/ije/dyab234
- The paper
- Unnarsdóttir, A. B., Lovik, A., Fawns-Ritchie, C., Ask, H., Kõiv, K., Hagen, K., Didriksen, M., Christoffersen, L. A. N., Garðarsson, A. B., McIntosh, A., Kähler, A. K., Campbell, A., Hauksdóttir, A., Erikstrup, C., Mikkelsen, D. H., Altschul, D., Thordardottir, E. B., Frans, E. M., Kvale, G., . . . Valdimarsdóttir, U. A. (2022). Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyab234
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.